Article
Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
14 Aug 2023
Abstract excerpt
Introduction: Pharmacogenetics (PGx) has the potential to improve health outcomes but cost of testing is a barrier for equitable access. Reimbursement by insurance providers may lessen the financial burden for patients, but the extent to which PGx claims are covered in clinical practice has not been well-characterized in the literature. Methods: A retrospective analysis of outpatient claims submitted to payers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
